Seyedkazemi Setareh 4
4 · Adverum Biotechnologies, Inc. · Filed May 16, 2025
Insider Transaction Report
Form 4
Seyedkazemi Setareh
CHIEF DEVELOPMENT OFFICER
Transactions
- Sale
Common Stock
2025-05-15$2.00/sh−924$1,848→ 13,768 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.98 to $2.01. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.